8-K
filed November 10, 2022, 6:59 PM ET
ticker DOCS
CIK 0001516513
earnings
confidence high
sentiment neutral
materiality 0.75
Doximity Q2 revenue $102.2M (+29% YoY), beats; net income down; $70M buyback authorized
Doximity, Inc.
2023-Q2 EPS reported
$0.23
revenue$192,824,000
- Q2 revenue $102.2M (+29% YoY); net income $26.3M (26% margin) vs $36.1M (45% margin) year ago.
- Non-GAAP EPS $0.17 vs $0.19; adjusted EBITDA $46.0M (45% margin) vs $32.8M (41% margin).
- Q3 guidance: revenue $110.7-111.7M, adjusted EBITDA $47.7-48.7M; FY23 revenue $424-432M reiterated.
- Board authorized $70M stock repurchase program over next 12 months, via open market or 10b5-1 plans.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Doximity, Inc. reported Fiscal year ending March 31, 2023 results: revenue between $424.0 million and $432.0 million. Guidance reaffirmed.
- Period
- Fiscal year ending March 31, 2023
- Revenue
- between $424.0 million and $432.0 million
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
Doximity is reiterating its guidance for its fiscal year ending March 31, 2023 as follows: • Revenue between $424.0 million and $432.0 million. • Adjusted EBITDA between $178.0 million and $186.0 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Doximity, Inc. reported Fiscal 2023 third quarter ending December 31, 2022 results: revenue between $110.7 million and $111.7 million. Guidance initiated.
- Period
- Fiscal 2023 third quarter ending December 31, 2022
- Revenue
- between $110.7 million and $111.7 million
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Doximity is providing guidance for its fiscal third quarter ending December 31, 2022 as follows: • Revenue between $110.7 million and $111.7 million. • Adjusted EBITDA between $47.7 million and $48.7 million.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.